Genotyping Market Size, Share & Trends Analysis Report By Technology (PCR, Capillary Electrophoresis, Microarrays, Sequencing, Mass Spectrometry), By Product, By Application, By End-use, By Region, And Segment Forecasts, 2022 - 2030
This report can be delivered to the clients within 72 Business Hours
Genotyping Market Growth & Trends
The global genotyping market size is expected to reach USD 46.5 billion by 2030, expanding at a CAGR of 15.6%, according to a new report by Grand View Research Inc. Factors such as the rising prevalence of genetic diseases, rising awareness and research for personalized medicine, and increasing R&D funding for genomics research is expected to contribute to this growth.
Governments in multiple countries are taking various initiatives to provide support and funding to research organizations for personalized medicine, and genotyping research is anticipated to drive the market. For instance, in August 2019, NIH funded USD 4.6 million initial grants to Color, a health technology company, for precision medicine initiatives and development. Similarly, in 2018, the Government of Australia launched the Australian Genomics Health Futures Mission initiative. The government will provide USD 500 million over a period of 10 years for this mission, and the funding will be sourced from Medical Research Future Fund to improve the testing and diagnosis of genetic diseases and for the development of personalized medicine.
An increase in the prevalence of diseases such as cancer, Alzheimer’s disease, and Parkinson’s disease is another factor that is anticipated to drive demand for genotyping-based diagnostic testing. For instance, Roche has products such as Cobas HCV GT products for cervical cancer diagnosis. Additionally, 23&Me provides genetic testing for medical conditions, such as Parkinson's disease and Alzheimer’s disease.
Failed clinical trials cost companies millions of dollars and therefore companies group patients according to their genotypes. Single Nucleotide Polymorphisms (SNP) based genotyping is increasingly being used in pharmacogenomics to study the effect of genetic variations on the difference in response to therapeutics. Genotyping-based treatment administration also helps in overall cost savings.
The COVID-19 pandemic increased the demand for genotyping-based research activities for the development of COVID diagnostics, vaccines, and therapeutics. Many companies, including Qiagen and Thermo Fisher Scientific, have now launched COVID-19 genotyping kits as a result of the growing demand.
Key players leverage strategic partnerships and new product launches to increase their product offerings. For instance, in January 2020, Illumina and Roche entered into a partnership for improving patient access to oncology genomic testing by assay development. Similarly, in June 2021, the Center for Aquaculture Technologies collaborated with Neogen Corporation to provide high-quality genotyping services tailored to aquaculture producers’ specific demands.
Genotyping Market Report Highlights
Genotyping Market Growth & Trends
The global genotyping market size is expected to reach USD 46.5 billion by 2030, expanding at a CAGR of 15.6%, according to a new report by Grand View Research Inc. Factors such as the rising prevalence of genetic diseases, rising awareness and research for personalized medicine, and increasing R&D funding for genomics research is expected to contribute to this growth.
Governments in multiple countries are taking various initiatives to provide support and funding to research organizations for personalized medicine, and genotyping research is anticipated to drive the market. For instance, in August 2019, NIH funded USD 4.6 million initial grants to Color, a health technology company, for precision medicine initiatives and development. Similarly, in 2018, the Government of Australia launched the Australian Genomics Health Futures Mission initiative. The government will provide USD 500 million over a period of 10 years for this mission, and the funding will be sourced from Medical Research Future Fund to improve the testing and diagnosis of genetic diseases and for the development of personalized medicine.
An increase in the prevalence of diseases such as cancer, Alzheimer’s disease, and Parkinson’s disease is another factor that is anticipated to drive demand for genotyping-based diagnostic testing. For instance, Roche has products such as Cobas HCV GT products for cervical cancer diagnosis. Additionally, 23&Me provides genetic testing for medical conditions, such as Parkinson's disease and Alzheimer’s disease.
Failed clinical trials cost companies millions of dollars and therefore companies group patients according to their genotypes. Single Nucleotide Polymorphisms (SNP) based genotyping is increasingly being used in pharmacogenomics to study the effect of genetic variations on the difference in response to therapeutics. Genotyping-based treatment administration also helps in overall cost savings.
The COVID-19 pandemic increased the demand for genotyping-based research activities for the development of COVID diagnostics, vaccines, and therapeutics. Many companies, including Qiagen and Thermo Fisher Scientific, have now launched COVID-19 genotyping kits as a result of the growing demand.
Key players leverage strategic partnerships and new product launches to increase their product offerings. For instance, in January 2020, Illumina and Roche entered into a partnership for improving patient access to oncology genomic testing by assay development. Similarly, in June 2021, the Center for Aquaculture Technologies collaborated with Neogen Corporation to provide high-quality genotyping services tailored to aquaculture producers’ specific demands.
Genotyping Market Report Highlights
- The reagents & kit segment accounted for the largest share of 61.6% in the market in 2021. This is attributed to increased demand for genetic testing, increased R&D spending, and increased genotyping testing volumes
- PCR segment dominated the market in 2021, whereas sequencing is expected to expand at the highest CAGR during the forecast period. This is due to advantages of the technique, such as low cost per sample, reduced bias as compared to arrays, comparative analysis across samples with no reference genome
- Pharmacogenomics is estimated to be the fastest-growing application segment during the forecast period due to increased usage of genotyping in drug development to reduce attrition of products in clinical development
- North America accounted for the largest market share in 2021, owing to proactive government measures, high disease prevalence, technological advancements, and advanced healthcare infrastructure
CHAPTER 1. METHODOLOGY AND SCOPE
1.1 Market Segmentation
1.1.1 Estimates And Forecast Timeline
1.2 Research Methodology
1.3 Information Procurement
1.3.1 Purchased Database
1.3.2 Secondary Sources
1.3.3 Primary Research
1.3.4 Details Of Primary Research
1.4 Information Or Data Analysis
1.4.1 Data Analysis Models
1.5 Market Formulation & Validation
1.6 Model Details
1.6.1 Commodity Flow Analysis
1.6.1.1 Approach 1: Commodity Flow Approach
1.6.1.2 Approach 2: Country-Wise Market Estimation Using The Bottom-Up Approach
1.7 Global Market: Cagr Calculation
1.8 Research Assumptions
1.9 List Of Secondary Sources
1.10 List Of Primary Sources
1.11 Objectives
1.11.1 Objective 1:
1.11.2 Objective 2:
1.12 List Of Abbreviations
CHAPTER 2. EXECUTIVE SUMMARY
2.1 Market Summary
CHAPTER 3. GENOTYPING MARKET VARIABLES, TRENDS & SCOPE
3.1 Genotyping Market Lineage Outlook
3.1.1 Parent Market Outlook
3.2 Penetration & Growth Prospect Mapping
3.3 Regulatory Framework
3.4 Market Dynamics
3.4.1 Market Driver Analysis
3.4.1.1 Rising Prevalence Of Genetic And Other Target Diseases
3.4.1.2 Increasing Focus On The Development Of Targeted Drugs And Personalized Medicine
3.4.1.3 Technological Advancements
3.4.1.4 Increase In Funding In Genomics
3.4.2 Market Restraint Analysis
3.4.2.1 Lack Of Skilled Labor
3.4.2.2 Ambiguous Reimbursement Policies
3.5 Genotyping Market Analysis Tools
3.5.1 Porter’s Five Forces Analysis
3.5.2 Swot Analysis; By Factor (Political & Legal, Economic And Technological)
CHAPTER 4. GENOTYPING MARKET - COMPETITIVE ANALYSIS
4.1 Recent Developments & Impact Analysis, By Key Market Participants
4.1.1 Company/Competition Categorization (Key Innovators, Market Leaders, Expansion)
4.1.2 Major Deals And Strategic Alliances
4.2 Vendor Landscape
4.2.1 List Of Key Distributors And Channel Partners
4.2.2 Key Company Market Share Analysis, 2021
4.3 Public Companies
4.3.1 Company Market Position Analysis
4.3.2 Competitive Dashboard Analysis
4.4 Private Companies
4.4.1 List Of Key Emerging Companies /Technology Disruptors/Innovators
4.4.2 Regional Network Map
CHAPTER 5. PRODUCT BUSINESS ANALYSIS
5.1 Genotyping Market: Product Movement Analysis
5.2 Instruments
5.2.1 Instruments Market, 2018 - 2030 (USD Million)
5.3 Reagents & Kits
5.3.1 Reagents & Kits Market, 2018 - 2030 (USD Million)
5.4 Software & Services
5.4.1 Software & Services Market, 2018 - 2030 (USD Million)
CHAPTER 6. APPLICATION BUSINESS ANALYSIS
6.1 Genotyping Market: Application Movement Analysis
6.2 Diagnostics & Personalized Medicine
6.2.1 Diagnostics & Personalized Medicine Market, 2018 - 2030 (USD Million)
6.3 Pharmacogenomics
6.3.1 Pharmacogenomics Market, 2018 - 2030 (USD Million)
6.4 Agricultural Biotechnology
6.4.1 Agricultural Biotechnology Market, 2018 - 2030 (USD Million)
6.3 Animal Genetics
6.3.1 Animal Genetics Market, 2018 - 2030 (USD Million)
6.6 Others
6.6.1 Others Market, 2018 - 2030 (USD Million)
CHAPTER 7. TECHNOLOGY BUSINESS ANALYSIS
7.1 Genotyping Market: Technology Movement Analysis
7.2 Pcr
7.2.1 Pcr Market, 2018 - 2030 (USD Million)
7.3 Capillary Electrophoresis
7.3.1 Capillary Electrophoresis Market, 2018 - 2030 (USD Million)
7.4 Microarrays
7.4.1 Microarrays Market, 2018 - 2030 (USD Million)
7.5 Sequencing
7.5.1 Sequencing Market, 2018 - 2030 (USD Million)
7.6 Mass Spectrometry
7.6.1 Mass Spectrometry Market, 2018 - 2030 (USD Million)
7.7 Others
7.7.1 Others Market, 2018 - 2030 (USD Million)
CHAPTER 8. END-USE BUSINESS ANALYSIS
8.1 Genotyping Market: End-Use Movement Analysis
8.2 Pharmaceutical And Biopharmaceutical Companies
8.2.1 Pharmaceutical And Biopharmaceutical Companies Market, 2018 - 2030 (USD Million)
8.3 Diagnostics And Research Laboratories
8.3.1 Diagnostics And Research Laboratories Market, 2018 - 2030 (USD Million)
8.4 Academic Institutes
8.4.1 Academic Institutes Market, 2018 - 2030 (USD Million)
8.5 Others
8.5.1 Others Market, 2018 - 2030 (USD Million)
CHAPTER 9. REGIONAL BUSINESS ANALYSIS
9.1 Genotyping Market: Regional Movement Analysis
9.1.1 North America
9.1.1.1 North America Market Estimates And Forecast, 2018 - 2030, USD Million
9.1.1.2 U.S.
9.1.1.2.1 U.S. Market Estimates And Forecast, 2018 - 2030, USD Million
9.1.1.3 Canada
9.1.1.3.1 Canada Market Estimates And Forecast, 2018 - 2030, USD Million
9.1.2 Europe
9.1.2.1 Europe Market Estimates And Forecast, 2018 - 2030, USD Million
9.1.2.2 Uk
9.1.2.2.1 Uk Market Estimates And Forecast, 2018 - 2030, USD Million
9.1.2.3 Germany
9.1.2.3.1 Germany Market Estimates And Forecast, 2018 - 2030, USD Million
9.1.2.4 France
9.1.2.4.1 France Market Estimates And Forecast, 2018 - 2030, USD Million
9.1.2.5 Spain
9.1.2.5.1 Spain Market Estimates And Forecast, 2018 - 2030, USD Million
9.1.2.6 Italy
9.1.2.6.1 Italy Market Estimates And Forecast, 2018 - 2030, USD Million
9.1.3 Asia Pacific
9.1.3.1 Asia Pacific Market Estimates And Forecast, 2018 - 2030, USD Million
9.1.3.2 Japan
9.1.3.2.1 Japan Market Estimates And Forecast, 2018 - 2030, USD Million
9.1.3.3 China
9.1.3.3.1 China Market Estimates And Forecast, 2018 - 2030, USD Million
9.1.3.4 India
9.1.3.4.1 India Market Estimates And Forecast, 2018 - 2030, USD Million
9.1.3.5 Australia
9.1.3.5.1 Australia Market Estimates And Forecast, 2018 - 2030, USD Million
9.1.3.6 South Korea
9.1.3.6.1 South Korea Market Estimates And Forecast, 2018 - 2030, USD Million
9.1.4 Latin America
9.1.4.1 Latin America Market Estimates And Forecast, 2018 - 2030, USD Million
9.1.4.2 Brazil
9.1.4.2.1 Brazil Market Estimates And Forecast, 2018 - 2030, USD Million
9.1.4.3 Mexico
9.1.4.3.1 Mexico Market Estimates And Forecast, 2018 - 2030, USD Million
9.1.4.4 Argentina
9.1.4.4.1 Argentina Market Estimates And Forecast, 2018 - 2030, USD Million
9.1.5 Middle East & Africa
9.1.5.1 Middle East & Africa Market Estimates And Forecast, 2018 - 2030, USD Million
9.1.5.2 South Africa
9.1.5.2.1 South Africa Market Estimates And Forecast, 2018 - 2030, USD Million
9.1.5.3 Saudi Arabia
9.1.5.3.1 Saudi Arabia Market Estimates And Forecast, 2018 - 2030, USD Million
9.1.5.5 United Arab Emirates
9.1.5.5.1 United Arab Emirates Market Estimates And Forecast, 2018 - 2030, USD Million
CHAPTER 10. COMPANY PROFILE
10.1 Market Participation Categorization
10.2 Company Profiles
10.2.1 Illumina Inc.
10.2.1.1 Company Overview
10.2.1.3 Financial Performance
10.2.1.4 Product Benchmarking
10.2.1.5 Strategic Initiatives
10.2.2 Thermo Fisher Scientific Inc.
10.2.2.1 Company Overview
10.2.2.2 Financial Performance
10.2.2.3 Product Benchmarking
10.2.2.4 Strategic Initiatives
10.2.3 Qiagen Inc.
10.2.3.1 Company Overview
10.2.3.2 Financial Performance
10.2.3.3 Product Benchmarking
10.2.3.4 Strategic Initiatives
10.2.4 F. Hoffman-La Roche Ltd.
10.2.4.1 Company Overview
10.2.4.2 Financial Performance
10.2.4.3 Product Benchmarking
10.2.4.4 Strategic Initiatives
10.2.5 Fluidigm Corporation
10.2.5.1 Company Overview
10.2.5.2 Financial Performance
10.2.5.3 Product Benchmarking
10.2.5.4 Strategic Initiatives
10.2.6 Danaher Corporation
10.2.5.1 Company Overview
10.2.5.2 Financial Performance
10.2.5.3 Product Benchmarking
10.2.5.4 Strategic Initiatives
10.2.7 Agilent Technologies
10.2.7.1 Company Overview
10.2.7.2 Financial Performance
10.2.7.3 Product Benchmarking
10.2.7.4 Strategic Initiatives
10.2.8 Eurofins Scientific Inc.
10.2.8.1 Company Overview
10.2.8.2 Financial Performance
10.2.8.3 Product Benchmarking
10.2.8.4 Strategic Initiatives
10.2.9 Ge Healthcare Inc.
10.2.9.1 Company Overview
10.2.9.2 Financial Performance
10.2.9.3 Product Benchmarking
10.2.9.4 Strategic Initiatives
10.2.10 Bio-Rad Laboratories Inc.
10.2.10.1 Company Overview
10.2.10.2 Financial Performance
10.2.10.3 Product Benchmarking
10.2.10.4 Strategic Initiatives
1.1 Market Segmentation
1.1.1 Estimates And Forecast Timeline
1.2 Research Methodology
1.3 Information Procurement
1.3.1 Purchased Database
1.3.2 Secondary Sources
1.3.3 Primary Research
1.3.4 Details Of Primary Research
1.4 Information Or Data Analysis
1.4.1 Data Analysis Models
1.5 Market Formulation & Validation
1.6 Model Details
1.6.1 Commodity Flow Analysis
1.6.1.1 Approach 1: Commodity Flow Approach
1.6.1.2 Approach 2: Country-Wise Market Estimation Using The Bottom-Up Approach
1.7 Global Market: Cagr Calculation
1.8 Research Assumptions
1.9 List Of Secondary Sources
1.10 List Of Primary Sources
1.11 Objectives
1.11.1 Objective 1:
1.11.2 Objective 2:
1.12 List Of Abbreviations
CHAPTER 2. EXECUTIVE SUMMARY
2.1 Market Summary
CHAPTER 3. GENOTYPING MARKET VARIABLES, TRENDS & SCOPE
3.1 Genotyping Market Lineage Outlook
3.1.1 Parent Market Outlook
3.2 Penetration & Growth Prospect Mapping
3.3 Regulatory Framework
3.4 Market Dynamics
3.4.1 Market Driver Analysis
3.4.1.1 Rising Prevalence Of Genetic And Other Target Diseases
3.4.1.2 Increasing Focus On The Development Of Targeted Drugs And Personalized Medicine
3.4.1.3 Technological Advancements
3.4.1.4 Increase In Funding In Genomics
3.4.2 Market Restraint Analysis
3.4.2.1 Lack Of Skilled Labor
3.4.2.2 Ambiguous Reimbursement Policies
3.5 Genotyping Market Analysis Tools
3.5.1 Porter’s Five Forces Analysis
3.5.2 Swot Analysis; By Factor (Political & Legal, Economic And Technological)
CHAPTER 4. GENOTYPING MARKET - COMPETITIVE ANALYSIS
4.1 Recent Developments & Impact Analysis, By Key Market Participants
4.1.1 Company/Competition Categorization (Key Innovators, Market Leaders, Expansion)
4.1.2 Major Deals And Strategic Alliances
4.2 Vendor Landscape
4.2.1 List Of Key Distributors And Channel Partners
4.2.2 Key Company Market Share Analysis, 2021
4.3 Public Companies
4.3.1 Company Market Position Analysis
4.3.2 Competitive Dashboard Analysis
4.4 Private Companies
4.4.1 List Of Key Emerging Companies /Technology Disruptors/Innovators
4.4.2 Regional Network Map
CHAPTER 5. PRODUCT BUSINESS ANALYSIS
5.1 Genotyping Market: Product Movement Analysis
5.2 Instruments
5.2.1 Instruments Market, 2018 - 2030 (USD Million)
5.3 Reagents & Kits
5.3.1 Reagents & Kits Market, 2018 - 2030 (USD Million)
5.4 Software & Services
5.4.1 Software & Services Market, 2018 - 2030 (USD Million)
CHAPTER 6. APPLICATION BUSINESS ANALYSIS
6.1 Genotyping Market: Application Movement Analysis
6.2 Diagnostics & Personalized Medicine
6.2.1 Diagnostics & Personalized Medicine Market, 2018 - 2030 (USD Million)
6.3 Pharmacogenomics
6.3.1 Pharmacogenomics Market, 2018 - 2030 (USD Million)
6.4 Agricultural Biotechnology
6.4.1 Agricultural Biotechnology Market, 2018 - 2030 (USD Million)
6.3 Animal Genetics
6.3.1 Animal Genetics Market, 2018 - 2030 (USD Million)
6.6 Others
6.6.1 Others Market, 2018 - 2030 (USD Million)
CHAPTER 7. TECHNOLOGY BUSINESS ANALYSIS
7.1 Genotyping Market: Technology Movement Analysis
7.2 Pcr
7.2.1 Pcr Market, 2018 - 2030 (USD Million)
7.3 Capillary Electrophoresis
7.3.1 Capillary Electrophoresis Market, 2018 - 2030 (USD Million)
7.4 Microarrays
7.4.1 Microarrays Market, 2018 - 2030 (USD Million)
7.5 Sequencing
7.5.1 Sequencing Market, 2018 - 2030 (USD Million)
7.6 Mass Spectrometry
7.6.1 Mass Spectrometry Market, 2018 - 2030 (USD Million)
7.7 Others
7.7.1 Others Market, 2018 - 2030 (USD Million)
CHAPTER 8. END-USE BUSINESS ANALYSIS
8.1 Genotyping Market: End-Use Movement Analysis
8.2 Pharmaceutical And Biopharmaceutical Companies
8.2.1 Pharmaceutical And Biopharmaceutical Companies Market, 2018 - 2030 (USD Million)
8.3 Diagnostics And Research Laboratories
8.3.1 Diagnostics And Research Laboratories Market, 2018 - 2030 (USD Million)
8.4 Academic Institutes
8.4.1 Academic Institutes Market, 2018 - 2030 (USD Million)
8.5 Others
8.5.1 Others Market, 2018 - 2030 (USD Million)
CHAPTER 9. REGIONAL BUSINESS ANALYSIS
9.1 Genotyping Market: Regional Movement Analysis
9.1.1 North America
9.1.1.1 North America Market Estimates And Forecast, 2018 - 2030, USD Million
9.1.1.2 U.S.
9.1.1.2.1 U.S. Market Estimates And Forecast, 2018 - 2030, USD Million
9.1.1.3 Canada
9.1.1.3.1 Canada Market Estimates And Forecast, 2018 - 2030, USD Million
9.1.2 Europe
9.1.2.1 Europe Market Estimates And Forecast, 2018 - 2030, USD Million
9.1.2.2 Uk
9.1.2.2.1 Uk Market Estimates And Forecast, 2018 - 2030, USD Million
9.1.2.3 Germany
9.1.2.3.1 Germany Market Estimates And Forecast, 2018 - 2030, USD Million
9.1.2.4 France
9.1.2.4.1 France Market Estimates And Forecast, 2018 - 2030, USD Million
9.1.2.5 Spain
9.1.2.5.1 Spain Market Estimates And Forecast, 2018 - 2030, USD Million
9.1.2.6 Italy
9.1.2.6.1 Italy Market Estimates And Forecast, 2018 - 2030, USD Million
9.1.3 Asia Pacific
9.1.3.1 Asia Pacific Market Estimates And Forecast, 2018 - 2030, USD Million
9.1.3.2 Japan
9.1.3.2.1 Japan Market Estimates And Forecast, 2018 - 2030, USD Million
9.1.3.3 China
9.1.3.3.1 China Market Estimates And Forecast, 2018 - 2030, USD Million
9.1.3.4 India
9.1.3.4.1 India Market Estimates And Forecast, 2018 - 2030, USD Million
9.1.3.5 Australia
9.1.3.5.1 Australia Market Estimates And Forecast, 2018 - 2030, USD Million
9.1.3.6 South Korea
9.1.3.6.1 South Korea Market Estimates And Forecast, 2018 - 2030, USD Million
9.1.4 Latin America
9.1.4.1 Latin America Market Estimates And Forecast, 2018 - 2030, USD Million
9.1.4.2 Brazil
9.1.4.2.1 Brazil Market Estimates And Forecast, 2018 - 2030, USD Million
9.1.4.3 Mexico
9.1.4.3.1 Mexico Market Estimates And Forecast, 2018 - 2030, USD Million
9.1.4.4 Argentina
9.1.4.4.1 Argentina Market Estimates And Forecast, 2018 - 2030, USD Million
9.1.5 Middle East & Africa
9.1.5.1 Middle East & Africa Market Estimates And Forecast, 2018 - 2030, USD Million
9.1.5.2 South Africa
9.1.5.2.1 South Africa Market Estimates And Forecast, 2018 - 2030, USD Million
9.1.5.3 Saudi Arabia
9.1.5.3.1 Saudi Arabia Market Estimates And Forecast, 2018 - 2030, USD Million
9.1.5.5 United Arab Emirates
9.1.5.5.1 United Arab Emirates Market Estimates And Forecast, 2018 - 2030, USD Million
CHAPTER 10. COMPANY PROFILE
10.1 Market Participation Categorization
10.2 Company Profiles
10.2.1 Illumina Inc.
10.2.1.1 Company Overview
10.2.1.3 Financial Performance
10.2.1.4 Product Benchmarking
10.2.1.5 Strategic Initiatives
10.2.2 Thermo Fisher Scientific Inc.
10.2.2.1 Company Overview
10.2.2.2 Financial Performance
10.2.2.3 Product Benchmarking
10.2.2.4 Strategic Initiatives
10.2.3 Qiagen Inc.
10.2.3.1 Company Overview
10.2.3.2 Financial Performance
10.2.3.3 Product Benchmarking
10.2.3.4 Strategic Initiatives
10.2.4 F. Hoffman-La Roche Ltd.
10.2.4.1 Company Overview
10.2.4.2 Financial Performance
10.2.4.3 Product Benchmarking
10.2.4.4 Strategic Initiatives
10.2.5 Fluidigm Corporation
10.2.5.1 Company Overview
10.2.5.2 Financial Performance
10.2.5.3 Product Benchmarking
10.2.5.4 Strategic Initiatives
10.2.6 Danaher Corporation
10.2.5.1 Company Overview
10.2.5.2 Financial Performance
10.2.5.3 Product Benchmarking
10.2.5.4 Strategic Initiatives
10.2.7 Agilent Technologies
10.2.7.1 Company Overview
10.2.7.2 Financial Performance
10.2.7.3 Product Benchmarking
10.2.7.4 Strategic Initiatives
10.2.8 Eurofins Scientific Inc.
10.2.8.1 Company Overview
10.2.8.2 Financial Performance
10.2.8.3 Product Benchmarking
10.2.8.4 Strategic Initiatives
10.2.9 Ge Healthcare Inc.
10.2.9.1 Company Overview
10.2.9.2 Financial Performance
10.2.9.3 Product Benchmarking
10.2.9.4 Strategic Initiatives
10.2.10 Bio-Rad Laboratories Inc.
10.2.10.1 Company Overview
10.2.10.2 Financial Performance
10.2.10.3 Product Benchmarking
10.2.10.4 Strategic Initiatives
LIST OF TABLES
Table 1 List of secondary sources
Table 2 List of Abbreviations
Table 3 North America genotyping market estimates and forecasts, by product, 2018 - 2030 (USD Million)
Table 4 North America genotyping market estimates and forecasts, by application, 2018 - 2030 (USD Million)
Table 5 North America genotyping market estimates and forecasts, by technology, 2018 - 2030 (USD Million)
Table 6 North America genotyping market estimates and forecasts, by end-use, 2018 - 2030 (USD Million)
Table 7 U.S. genotyping market estimates and forecasts, by product, 2018 - 2030 (USD Million)
Table 8 U.S. genotyping market estimates and forecasts, by application, 2018 - 2030 (USD Million)
Table 9 U.S. genotyping market estimates and forecasts, by technology, 2018 - 2030 (USD Million)
Table 10 U.S. genotyping market estimates and forecasts, by end-use, 2018 - 2030 (USD Million)
Table 11 Canada genotyping market estimates and forecasts, by product, 2018 - 2030 (USD Million)
Table 12 Canada genotyping market estimates and forecasts, by application, 2018 - 2030 (USD Million)
Table 13 Canada genotyping market estimates and forecasts, by technology, 2018 - 2030 (USD Million)
Table 14 Canada genotyping market estimates and forecasts, by end-use, 2018 - 2030 (USD Million)
Table 15 Europe genotyping market estimates and forecasts, by product, 2018 - 2030 (USD Million)
Table 16 Europe genotyping market estimates and forecasts, by application, 2018 - 2030 (USD Million)
Table 17 Europe genotyping market estimates and forecasts, by technology, 2018 - 2030 (USD Million)
Table 18 Europe genotyping market estimates and forecasts, by end-use, 2018 - 2030 (USD Million)
Table 19 UK genotyping market estimates and forecasts, by product, 2018 - 2030 (USD Million)
Table 20 UK genotyping market estimates and forecasts, by application, 2018 - 2030 (USD Million)
Table 21 UK genotyping market estimates and forecasts, by technology, 2018 - 2030 (USD Million)
Table 22 UK genotyping market estimates and forecasts, by end-use, 2018 - 2030 (USD Million)
Table 23 Germany genotyping market estimates and forecasts, by product, 2018 - 2030 (USD Million)
Table 24 Germany genotyping market estimates and forecasts, by application, 2018 - 2030 (USD Million)
Table 25 Germany genotyping market estimates and forecasts, by technology, 2018 - 2030 (USD Million)
Table 26 Germany genotyping market estimates and forecasts, by end-use, 2018 - 2030 (USD Million)
Table 27 France genotyping market estimates and forecasts, by product, 2018 - 2030 (USD Million)
Table 28 France genotyping market estimates and forecasts, by application, 2018 - 2030 (USD Million)
Table 29 France genotyping market estimates and forecasts, by technology, 2018 - 2030 (USD Million)
Table 30 France genotyping market estimates and forecasts, by end-use, 2018 - 2030 (USD Million)
Table 31 Italy genotyping market estimates and forecasts, by product, 2018 - 2030 (USD Million)
Table 32 Italy genotyping market estimates and forecasts, by application, 2018 - 2030 (USD Million)
Table 33 Italy genotyping market estimates and forecasts, by technology, 2018 - 2030 (USD Million)
Table 34 Italy genotyping market estimates and forecasts, by end-use, 2018 - 2030 (USD Million)
Table 35 Spain genotyping market estimates and forecasts, by product, 2018 - 2030 (USD Million)
Table 36 Spain genotyping market estimates and forecasts, by application, 2018 - 2030 (USD Million)
Table 37 Spain genotyping market estimates and forecasts, by technology, 2018 - 2030 (USD Million)
Table 38 Spain genotyping market estimates and forecasts, by end-use, 2018 - 2030 (USD Million)
Table 39 Asia Pacific genotyping market estimates and forecasts, by product, 2018 - 2030 (USD Million)
Table 40 Asia Pacific genotyping market estimates and forecasts, by application, 2018 - 2030 (USD Million)
Table 41 Asia Pacific genotyping market estimates and forecasts, by technology, 2018 - 2030 (USD Million)
Table 42 Asia Pacific genotyping market estimates and forecasts, by end-use, 2018 - 2030 (USD Million)
Table 43 Japan genotyping market estimates and forecasts, by product, 2018 - 2030 (USD Million)
Table 44 Japan genotyping market estimates and forecasts, by application, 2018 - 2030 (USD Million)
Table 45 Japan genotyping market estimates and forecasts, by technology, 2018 - 2030 (USD Million)
Table 46 Japan genotyping market estimates and forecasts, by end-use, 2018 - 2030 (USD Million)
Table 47 China genotyping market estimates and forecasts, by product, 2018 - 2030 (USD Million)
Table 48 China genotyping market estimates and forecasts, by application, 2018 - 2030 (USD Million)
Table 49 China genotyping market estimates and forecasts, by technology, 2018 - 2030 (USD Million)
Table 50 China genotyping market estimates and forecasts, by end-use, 2018 - 2030 (USD Million)
Table 51 India genotyping market estimates and forecasts, by product, 2018 - 2030 (USD Million)
Table 52 India genotyping market estimates and forecasts, by application, 2018 - 2030 (USD Million)
Table 53 India genotyping market estimates and forecasts, by technology, 2018 - 2030 (USD Million)
Table 54 India genotyping market estimates and forecasts, by end-use, 2018 - 2030 (USD Million)
Table 55 Australia genotyping market estimates and forecasts, by product, 2018 - 2030 (USD Million)
Table 56 Australia genotyping market estimates and forecasts, by application, 2018 - 2030 (USD Million)
Table 57 Australia genotyping market estimates and forecasts, by technology, 2018 - 2030 (USD Million)
Table 58 Australia genotyping market estimates and forecasts, by end-use, 2018 - 2030 (USD Million)
Table 59 South Korea genotyping market estimates and forecasts, by product, 2018 - 2030 (USD Million)
Table 60 South Korea genotyping market estimates and forecasts, by application, 2018 - 2030 (USD Million)
Table 61 South Korea genotyping market estimates and forecasts, by technology, 2018 - 2030 (USD Million)
Table 62 South Korea genotyping market estimates and forecasts, by end-use, 2018 - 2030 (USD Million)
Table 63 Latin America genotyping market estimates and forecasts, by product, 2018 - 2030 (USD Million)
Table 64 Latin America genotyping market estimates and forecasts, by application, 2018 - 2030 (USD Million)
Table 65 Latin America genotyping market estimates and forecasts, by technology, 2018 - 2030 (USD Million)
Table 66 Latin America genotyping market estimates and forecasts, by end-use, 2018 - 2030 (USD Million)
Table 67 Brazil genotyping market estimates and forecasts, by product, 2018 - 2030 (USD Million)
Table 68 Brazil genotyping market estimates and forecasts, by application, 2018 - 2030 (USD Million)
Table 69 Brazil genotyping market estimates and forecasts, by technology, 2018 - 2030 (USD Million)
Table 70 Brazil genotyping market estimates and forecasts, by end-use, 2018 - 2030 (USD Million)
Table 71 Mexico genotyping market estimates and forecasts, by product, 2018 - 2030 (USD Million)
Table 72 Mexico genotyping market estimates and forecasts, by application, 2018 - 2030 (USD Million)
Table 73 Mexico genotyping market estimates and forecasts, by technology, 2018 - 2030 (USD Million)
Table 74 Mexico genotyping market estimates and forecasts, by end-use, 2018 - 2030 (USD Million)
Table 75 Argentina genotyping market estimates and forecasts, by product, 2018 - 2030 (USD Million)
Table 76 Argentina genotyping market estimates and forecasts, by application, 2018 - 2030 (USD Million)
Table 77 Argentina genotyping market estimates and forecasts, by technology, 2018 - 2030 (USD Million)
Table 78 Argentina genotyping market estimates and forecasts, by end-use, 2018 - 2030 (USD Million)
Table 79 MEA genotyping market estimates and forecasts, by product, 2018 - 2030 (USD Million)
Table 80 MEA genotyping market estimates and forecasts, by application, 2018 - 2030 (USD Million)
Table 81 MEA genotyping market estimates and forecasts, by technology, 2018 - 2030 (USD Million)
Table 82 MEA genotyping market estimates and forecasts, by end-use, 2018 - 2030 (USD Million)
Table 8 South Africa genotyping market estimates and forecasts, by product, 2018 - 2030 (USD Million)
Table 82 South Africa genotyping market estimates and forecasts, by application, 2018 - 2030 (USD Million)
Table 83 South Africa genotyping market estimates and forecasts, by technology, 2018 - 2030 (USD Million)
Table 84 South Africa genotyping market estimates and forecasts, by end-use, 2018 - 2030 (USD Million)
Table 85 Saudi Arabia genotyping market estimates and forecasts, by product, 2018 - 2030 (USD Million)
Table 86 Saudi Arabia genotyping market estimates and forecasts, by application, 2018 - 2030 (USD Million)
Table 87 Saudi Arabia genotyping market estimates and forecasts, by technology, 2018 - 2030 (USD Million)
Table 88 Saudi Arabia genotyping market estimates and forecasts, by end-use, 2018 - 2030 (USD Million)
Table 90 UAE genotyping market estimates and forecasts, by product, 2018 - 2030 (USD Million)
Table 91 UAE genotyping market estimates and forecasts, by application, 2018 - 2030 (USD Million)
Table 92 UAE genotyping market estimates and forecasts, by technology, 2018 - 2030 (USD Million)
Table 93 UAE genotyping market estimates and forecasts, by end-use, 2018 - 2030 (USD Million)
Table 94 List of key distributors
Table 1 List of secondary sources
Table 2 List of Abbreviations
Table 3 North America genotyping market estimates and forecasts, by product, 2018 - 2030 (USD Million)
Table 4 North America genotyping market estimates and forecasts, by application, 2018 - 2030 (USD Million)
Table 5 North America genotyping market estimates and forecasts, by technology, 2018 - 2030 (USD Million)
Table 6 North America genotyping market estimates and forecasts, by end-use, 2018 - 2030 (USD Million)
Table 7 U.S. genotyping market estimates and forecasts, by product, 2018 - 2030 (USD Million)
Table 8 U.S. genotyping market estimates and forecasts, by application, 2018 - 2030 (USD Million)
Table 9 U.S. genotyping market estimates and forecasts, by technology, 2018 - 2030 (USD Million)
Table 10 U.S. genotyping market estimates and forecasts, by end-use, 2018 - 2030 (USD Million)
Table 11 Canada genotyping market estimates and forecasts, by product, 2018 - 2030 (USD Million)
Table 12 Canada genotyping market estimates and forecasts, by application, 2018 - 2030 (USD Million)
Table 13 Canada genotyping market estimates and forecasts, by technology, 2018 - 2030 (USD Million)
Table 14 Canada genotyping market estimates and forecasts, by end-use, 2018 - 2030 (USD Million)
Table 15 Europe genotyping market estimates and forecasts, by product, 2018 - 2030 (USD Million)
Table 16 Europe genotyping market estimates and forecasts, by application, 2018 - 2030 (USD Million)
Table 17 Europe genotyping market estimates and forecasts, by technology, 2018 - 2030 (USD Million)
Table 18 Europe genotyping market estimates and forecasts, by end-use, 2018 - 2030 (USD Million)
Table 19 UK genotyping market estimates and forecasts, by product, 2018 - 2030 (USD Million)
Table 20 UK genotyping market estimates and forecasts, by application, 2018 - 2030 (USD Million)
Table 21 UK genotyping market estimates and forecasts, by technology, 2018 - 2030 (USD Million)
Table 22 UK genotyping market estimates and forecasts, by end-use, 2018 - 2030 (USD Million)
Table 23 Germany genotyping market estimates and forecasts, by product, 2018 - 2030 (USD Million)
Table 24 Germany genotyping market estimates and forecasts, by application, 2018 - 2030 (USD Million)
Table 25 Germany genotyping market estimates and forecasts, by technology, 2018 - 2030 (USD Million)
Table 26 Germany genotyping market estimates and forecasts, by end-use, 2018 - 2030 (USD Million)
Table 27 France genotyping market estimates and forecasts, by product, 2018 - 2030 (USD Million)
Table 28 France genotyping market estimates and forecasts, by application, 2018 - 2030 (USD Million)
Table 29 France genotyping market estimates and forecasts, by technology, 2018 - 2030 (USD Million)
Table 30 France genotyping market estimates and forecasts, by end-use, 2018 - 2030 (USD Million)
Table 31 Italy genotyping market estimates and forecasts, by product, 2018 - 2030 (USD Million)
Table 32 Italy genotyping market estimates and forecasts, by application, 2018 - 2030 (USD Million)
Table 33 Italy genotyping market estimates and forecasts, by technology, 2018 - 2030 (USD Million)
Table 34 Italy genotyping market estimates and forecasts, by end-use, 2018 - 2030 (USD Million)
Table 35 Spain genotyping market estimates and forecasts, by product, 2018 - 2030 (USD Million)
Table 36 Spain genotyping market estimates and forecasts, by application, 2018 - 2030 (USD Million)
Table 37 Spain genotyping market estimates and forecasts, by technology, 2018 - 2030 (USD Million)
Table 38 Spain genotyping market estimates and forecasts, by end-use, 2018 - 2030 (USD Million)
Table 39 Asia Pacific genotyping market estimates and forecasts, by product, 2018 - 2030 (USD Million)
Table 40 Asia Pacific genotyping market estimates and forecasts, by application, 2018 - 2030 (USD Million)
Table 41 Asia Pacific genotyping market estimates and forecasts, by technology, 2018 - 2030 (USD Million)
Table 42 Asia Pacific genotyping market estimates and forecasts, by end-use, 2018 - 2030 (USD Million)
Table 43 Japan genotyping market estimates and forecasts, by product, 2018 - 2030 (USD Million)
Table 44 Japan genotyping market estimates and forecasts, by application, 2018 - 2030 (USD Million)
Table 45 Japan genotyping market estimates and forecasts, by technology, 2018 - 2030 (USD Million)
Table 46 Japan genotyping market estimates and forecasts, by end-use, 2018 - 2030 (USD Million)
Table 47 China genotyping market estimates and forecasts, by product, 2018 - 2030 (USD Million)
Table 48 China genotyping market estimates and forecasts, by application, 2018 - 2030 (USD Million)
Table 49 China genotyping market estimates and forecasts, by technology, 2018 - 2030 (USD Million)
Table 50 China genotyping market estimates and forecasts, by end-use, 2018 - 2030 (USD Million)
Table 51 India genotyping market estimates and forecasts, by product, 2018 - 2030 (USD Million)
Table 52 India genotyping market estimates and forecasts, by application, 2018 - 2030 (USD Million)
Table 53 India genotyping market estimates and forecasts, by technology, 2018 - 2030 (USD Million)
Table 54 India genotyping market estimates and forecasts, by end-use, 2018 - 2030 (USD Million)
Table 55 Australia genotyping market estimates and forecasts, by product, 2018 - 2030 (USD Million)
Table 56 Australia genotyping market estimates and forecasts, by application, 2018 - 2030 (USD Million)
Table 57 Australia genotyping market estimates and forecasts, by technology, 2018 - 2030 (USD Million)
Table 58 Australia genotyping market estimates and forecasts, by end-use, 2018 - 2030 (USD Million)
Table 59 South Korea genotyping market estimates and forecasts, by product, 2018 - 2030 (USD Million)
Table 60 South Korea genotyping market estimates and forecasts, by application, 2018 - 2030 (USD Million)
Table 61 South Korea genotyping market estimates and forecasts, by technology, 2018 - 2030 (USD Million)
Table 62 South Korea genotyping market estimates and forecasts, by end-use, 2018 - 2030 (USD Million)
Table 63 Latin America genotyping market estimates and forecasts, by product, 2018 - 2030 (USD Million)
Table 64 Latin America genotyping market estimates and forecasts, by application, 2018 - 2030 (USD Million)
Table 65 Latin America genotyping market estimates and forecasts, by technology, 2018 - 2030 (USD Million)
Table 66 Latin America genotyping market estimates and forecasts, by end-use, 2018 - 2030 (USD Million)
Table 67 Brazil genotyping market estimates and forecasts, by product, 2018 - 2030 (USD Million)
Table 68 Brazil genotyping market estimates and forecasts, by application, 2018 - 2030 (USD Million)
Table 69 Brazil genotyping market estimates and forecasts, by technology, 2018 - 2030 (USD Million)
Table 70 Brazil genotyping market estimates and forecasts, by end-use, 2018 - 2030 (USD Million)
Table 71 Mexico genotyping market estimates and forecasts, by product, 2018 - 2030 (USD Million)
Table 72 Mexico genotyping market estimates and forecasts, by application, 2018 - 2030 (USD Million)
Table 73 Mexico genotyping market estimates and forecasts, by technology, 2018 - 2030 (USD Million)
Table 74 Mexico genotyping market estimates and forecasts, by end-use, 2018 - 2030 (USD Million)
Table 75 Argentina genotyping market estimates and forecasts, by product, 2018 - 2030 (USD Million)
Table 76 Argentina genotyping market estimates and forecasts, by application, 2018 - 2030 (USD Million)
Table 77 Argentina genotyping market estimates and forecasts, by technology, 2018 - 2030 (USD Million)
Table 78 Argentina genotyping market estimates and forecasts, by end-use, 2018 - 2030 (USD Million)
Table 79 MEA genotyping market estimates and forecasts, by product, 2018 - 2030 (USD Million)
Table 80 MEA genotyping market estimates and forecasts, by application, 2018 - 2030 (USD Million)
Table 81 MEA genotyping market estimates and forecasts, by technology, 2018 - 2030 (USD Million)
Table 82 MEA genotyping market estimates and forecasts, by end-use, 2018 - 2030 (USD Million)
Table 8 South Africa genotyping market estimates and forecasts, by product, 2018 - 2030 (USD Million)
Table 82 South Africa genotyping market estimates and forecasts, by application, 2018 - 2030 (USD Million)
Table 83 South Africa genotyping market estimates and forecasts, by technology, 2018 - 2030 (USD Million)
Table 84 South Africa genotyping market estimates and forecasts, by end-use, 2018 - 2030 (USD Million)
Table 85 Saudi Arabia genotyping market estimates and forecasts, by product, 2018 - 2030 (USD Million)
Table 86 Saudi Arabia genotyping market estimates and forecasts, by application, 2018 - 2030 (USD Million)
Table 87 Saudi Arabia genotyping market estimates and forecasts, by technology, 2018 - 2030 (USD Million)
Table 88 Saudi Arabia genotyping market estimates and forecasts, by end-use, 2018 - 2030 (USD Million)
Table 90 UAE genotyping market estimates and forecasts, by product, 2018 - 2030 (USD Million)
Table 91 UAE genotyping market estimates and forecasts, by application, 2018 - 2030 (USD Million)
Table 92 UAE genotyping market estimates and forecasts, by technology, 2018 - 2030 (USD Million)
Table 93 UAE genotyping market estimates and forecasts, by end-use, 2018 - 2030 (USD Million)
Table 94 List of key distributors
LIST OF FIGURES
Fig. 1 Genotyping market segmentation
Fig. 2 Market research process
Fig. 3 Information procurement
Fig. 4 Primary research pattern
Fig. 5 Market research approaches
Fig. 6 Value-chain-based sizing & forecasting
Fig. 7 QFD modeling for market share assessment
Fig. 8 Market formulation & validation
Fig. 9 Genotyping market snapshot
Fig. 10 Genotyping market driver impact
Fig. 11 Genotyping market restraint impact
Fig. 12 Penetration and growth prospect mapping
Fig. 13 SWOT analysis, by factor (political & legal economic, and technological)
Fig. 14 Porter’s five forces analysis
Fig. 15 Genotyping market: Product movement analysis
Fig. 16 Genotyping product outlook: Key takeaways
Fig. 17 Instruments market, 2018 - 2030 (USD million)
Fig. 18 Reagents & Kits market, 2018 - 2030 (USD million)
Fig. 19 Software & Services market, 2018 - 2030 (USD million)
Fig. 20 Genotyping market: Technology movement analysis
Fig. 21 Genotyping technology outlook: Key takeaways
Fig. 22 PCR market, 2018 - 2030 (USD million)
Fig. 23 Capillary Electrophoresis market, 2018 - 2030 (USD million)
Fig. 24 Microarrays market, 2018 - 2030 (USD million)
Fig. 25 Mass Spectrometry market, 2018 - 2030 (USD million)
Fig. 26 Others market, 2018 - 2030 (USD million)
Fig. 27 Genotyping market: Application movement analysis
Fig. 28 Genotyping application outlook: Key takeaways
Fig. 29 Diagnostics & personalized medicine market, 2018 - 2030 (USD million)
Fig. 30 Pharmacogenomics market, 2018 - 2030 (USD million)
Fig. 31 Agricultural biotechnology market, 2018 - 2030 (USD million)
Fig. 32 Animal genetics market, 2018 - 2030 (USD million)
Fig. 33 Others market, 2018 - 2030 (USD million)
Fig. 34 Genotyping market: End-use movement analysis
Fig. 35 Genotyping end-use outlook: Key takeaways
Fig. 36 Pharmaceutical and biopharmaceutical companies market, 2018 - 2030 (USD million)
Fig. 37 Diagnostics and research laboratories market, 2018 - 2030 (USD million)
Fig. 38 Academic institutes market, 2018 - 2030 (USD million)
Fig. 39 Others market, 2018 - 2030 (USD million)
Fig. 40 Genotyping market: Regional outlook and key takeaways
Fig. 41 Genotyping market: Regional movement analysis
Fig. 42 North America
Fig. 43 North America market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 44 U.S.
Fig. 45 U.S. market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 46 Canada
Fig. 47 Canada market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 48 Europe
Fig. 49 Europe market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 50 UK
Fig. 51 UK market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 52 Germany
Fig. 53 Germany market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 54 Italy
Fig. 55 Italy market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 56 Spain
Fig. 57 Spain market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 58 France
Fig. 59 France market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 60 Asia Pacific
Fig. 61 Asia Pacific market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 62 Japan
Fig. 63 Japan market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 64 China
Fig. 65 China market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 66 India
Fig. 67 India market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 68 Australia
Fig. 69 Australia market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 70 South Korea
Fig. 71 South Korea market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 72 Latin America
Fig. 73 Latin America market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 74 Brazil
Fig. 75 Brazil market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 76 Mexico
Fig. 77 Mexico market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 78 Argentina
Fig. 79 Argentina market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 80 Middle East & Africa
Fig. 81 Middle East and Africa market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 82 South Africa
Fig. 83 South Africa market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 84 Saudi Arabia
Fig. 85 Saudi Arabia market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 86 UAE
Fig. 87 UAE market estimates and forecast, 2018 - 2030 (USD Million)
FIG.88 Company market share analysis
FIG.89 Company market position analysis (Revenue US$ mn)
FIG.90 Company market position analysis (Profit Margin)
Fig. 91Competitive dashboard analysis
Fig. 92 Regional Network Map
Fig. 1 Genotyping market segmentation
Fig. 2 Market research process
Fig. 3 Information procurement
Fig. 4 Primary research pattern
Fig. 5 Market research approaches
Fig. 6 Value-chain-based sizing & forecasting
Fig. 7 QFD modeling for market share assessment
Fig. 8 Market formulation & validation
Fig. 9 Genotyping market snapshot
Fig. 10 Genotyping market driver impact
Fig. 11 Genotyping market restraint impact
Fig. 12 Penetration and growth prospect mapping
Fig. 13 SWOT analysis, by factor (political & legal economic, and technological)
Fig. 14 Porter’s five forces analysis
Fig. 15 Genotyping market: Product movement analysis
Fig. 16 Genotyping product outlook: Key takeaways
Fig. 17 Instruments market, 2018 - 2030 (USD million)
Fig. 18 Reagents & Kits market, 2018 - 2030 (USD million)
Fig. 19 Software & Services market, 2018 - 2030 (USD million)
Fig. 20 Genotyping market: Technology movement analysis
Fig. 21 Genotyping technology outlook: Key takeaways
Fig. 22 PCR market, 2018 - 2030 (USD million)
Fig. 23 Capillary Electrophoresis market, 2018 - 2030 (USD million)
Fig. 24 Microarrays market, 2018 - 2030 (USD million)
Fig. 25 Mass Spectrometry market, 2018 - 2030 (USD million)
Fig. 26 Others market, 2018 - 2030 (USD million)
Fig. 27 Genotyping market: Application movement analysis
Fig. 28 Genotyping application outlook: Key takeaways
Fig. 29 Diagnostics & personalized medicine market, 2018 - 2030 (USD million)
Fig. 30 Pharmacogenomics market, 2018 - 2030 (USD million)
Fig. 31 Agricultural biotechnology market, 2018 - 2030 (USD million)
Fig. 32 Animal genetics market, 2018 - 2030 (USD million)
Fig. 33 Others market, 2018 - 2030 (USD million)
Fig. 34 Genotyping market: End-use movement analysis
Fig. 35 Genotyping end-use outlook: Key takeaways
Fig. 36 Pharmaceutical and biopharmaceutical companies market, 2018 - 2030 (USD million)
Fig. 37 Diagnostics and research laboratories market, 2018 - 2030 (USD million)
Fig. 38 Academic institutes market, 2018 - 2030 (USD million)
Fig. 39 Others market, 2018 - 2030 (USD million)
Fig. 40 Genotyping market: Regional outlook and key takeaways
Fig. 41 Genotyping market: Regional movement analysis
Fig. 42 North America
Fig. 43 North America market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 44 U.S.
Fig. 45 U.S. market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 46 Canada
Fig. 47 Canada market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 48 Europe
Fig. 49 Europe market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 50 UK
Fig. 51 UK market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 52 Germany
Fig. 53 Germany market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 54 Italy
Fig. 55 Italy market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 56 Spain
Fig. 57 Spain market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 58 France
Fig. 59 France market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 60 Asia Pacific
Fig. 61 Asia Pacific market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 62 Japan
Fig. 63 Japan market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 64 China
Fig. 65 China market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 66 India
Fig. 67 India market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 68 Australia
Fig. 69 Australia market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 70 South Korea
Fig. 71 South Korea market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 72 Latin America
Fig. 73 Latin America market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 74 Brazil
Fig. 75 Brazil market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 76 Mexico
Fig. 77 Mexico market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 78 Argentina
Fig. 79 Argentina market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 80 Middle East & Africa
Fig. 81 Middle East and Africa market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 82 South Africa
Fig. 83 South Africa market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 84 Saudi Arabia
Fig. 85 Saudi Arabia market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 86 UAE
Fig. 87 UAE market estimates and forecast, 2018 - 2030 (USD Million)
FIG.88 Company market share analysis
FIG.89 Company market position analysis (Revenue US$ mn)
FIG.90 Company market position analysis (Profit Margin)
Fig. 91Competitive dashboard analysis
Fig. 92 Regional Network Map
